SPECIFIC TARGETING OF INFECTIOUS FOCI WITH RADIOIODINATED HUMAN RECOMBINANT INTERLEUKIN-1 IN AN EXPERIMENTAL-MODEL

被引:51
作者
VANDERLAKEN, CJ [1 ]
BOERMAN, OC [1 ]
OYEN, WJG [1 ]
VANDEVEN, MTP [1 ]
CLAESSENS, RAMJ [1 ]
VANDERMEER, JWM [1 ]
CORSTENS, FHM [1 ]
机构
[1] UNIV NIJMEGEN HOSP, DEPT INTERNAL MED, 6500 HB NIJMEGEN, NETHERLANDS
来源
EUROPEAN JOURNAL OF NUCLEAR MEDICINE | 1995年 / 22卷 / 11期
关键词
RADIOIODINATION; INTERLEUKIN-1; INFECTION; BIODISTRIBUTION; RADIONUCLIDE IMAGING;
D O I
10.1007/BF00801608
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
In the present study, radioiodinated human recombinant interleukin-1 (IL-1) was investigated for its potential to image infectious foci in vivo in an animal model of infection. Twenty-four hours after induction of a Staphylococcus aureus abscess in the left calf muscle, mice were i.v. injected with both iodine-125 labelled IL-1 and iodine-131 labelled myoglobin, a size-matched control agent. The animals were killed for tissue biodistribution studies at 2, 6, 12, 24 and 48 h p.i. Gamma camera images were obtained at 6, 24 and 48 h after injecting mice with I-123-IL-1. Radioiodinated IL-1 rapidly cleared from the body; after 12 h the abscess was the organ with the highest activity. The absolute abscess uptake of I-125-IL-1 remained high compared to I-131-myoglobin, resulting in significantly higher abscess-to-muscle ratios of I-125-IL-1 compared to I-131-myoglobin. The ratios of I-125-IL-1 reached the ultimate value of 44.4+/-10.8 at 48 h p.i., whereas the ratios of I-131-myoglobin did not exceed 5.9+/-0.7. Gamma camera imaging revealed clearly visible abscesses. In conclusion, our results demonstrate specific retention of radioiodinated IL-1 in the abscess, presumably by interaction of IL-1 with its receptor on the inflammatory cells. The high target-to-background ratios that were obtained over the course of time indicate that the IL-1 receptor may be a valuable target for the imaging of infectious foci.
引用
收藏
页码:1249 / 1255
页数:7
相关论文
共 23 条
[1]   INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY [J].
AREND, WP .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1445-1451
[2]  
BABICH JW, 1993, J NUCL MED, V34, P2176
[3]   STRUCTURE OF AN INTERLEUKIN-1-BETA MUTANT WITH REDUCED BIOACTIVITY SHOWS MULTIPLE SUBTLE CHANGES IN CONFORMATION THAT AFFECT PROTEIN-PROTEIN RECOGNITION [J].
CAMACHO, NP ;
SMITH, DR ;
GOLDMAN, A ;
SCHNEIDER, B ;
GREEN, D ;
YOUNG, PR ;
BERMAN, HM .
BIOCHEMISTRY, 1993, 32 (34) :8749-8757
[4]  
CORSTENS FHM, 1991, J NUCL MED, V32, P491
[5]   RADIOIMMUNOCONJUGATES IN THE DETECTION OF INFECTION AND INFLAMMATION [J].
CORSTENS, FHM ;
OYEN, WJG ;
BECKER, WS .
SEMINARS IN NUCLEAR MEDICINE, 1993, 23 (02) :148-164
[6]  
DINARELLO CA, 1991, BLOOD, V77, P1627
[7]  
FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
[8]  
GEHRKE L, 1990, J BIOL CHEM, V265, P5922
[9]  
GOINS B, 1993, J NUCL MED, V34, P2160
[10]   PHARMACOKINETICS, SAFETY AND IMMUNOMODULATORY EFFECTS OF HUMAN RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST IN HEALTHY HUMANS [J].
GRANOWTIZ, EV ;
PORAT, R ;
MIER, JW ;
PRIBBLE, JP ;
STILES, DM ;
BLOEDOW, DC ;
CATALANO, MA ;
WOLFF, SM ;
DINARELLO, CA .
CYTOKINE, 1992, 4 (05) :353-360